Coinfection of Hepatitis B and C in HIV Patients: A Review of the State of the Art
Open Access
- 8 April 2020
- book chapter
- Published by IntechOpen
Abstract
Infection with the human immunodeficiency virus (HIV) modifies the course of infection by the virus of hepatitis B (HBV) by several mechanisms: the rate of chronicity, prolonging viremia by HBV, and increase in morbidity related to liver disease. The treatment for both infections should be done in a coordinated manner, to avoid the emergence of resistance in HIV, HBV or both, as well as major alterations in the hepatic enzymes. Monotherapies with lamivudine or emtricitabine select, rapidly, mutant strains of the HBV and HIV. Monotherapy with adefovir has moderate effects in coinfected patients as they already have mutations. If the treatment of HBV can defer until the combination antiretroviral therapy of HIV is necessary, these patients should receive a combination of tenofovir plus lamivudine (or emtricitabine), since this provides a powerful therapy against HBV and establishes a good central axis for antiretroviral therapy. In addition, it would prevent the selection of HBV variant resistance. The influence of HIV in the HCV infection. Increase in load HIV-driven viral hepatitis exacerbates hepatic lesions and influences transmission of the HCV. The risk of sexual transmission increases when HIV is present in the carrier. Coinfection modifies the evolution of fibrosis in patients with HIV, with higher speed in those who have low CD4 counts, so that the onset of cirrhosis occurs before, and the risk of liver decompensation is also more frequent. The consequence of this situation is an increase in liver-related morbidity and mortality.Keywords
This publication has 62 references indexed in Scilit:
- HIV and viral hepatitis coinfections: advances and challengesGut, 2012
- Randomized trial comparing pegylated interferon α‐2b versus pegylated interferon α‐2a, both plus ribavirin, to treat chronic hepatitis C in human immunodeficiency virus patients†Hepatology, 2009
- Clinical progression of hepatitis C virus–related chronic liver disease in human immunodeficiency virus–infected patients undergoing highly active antiretroviral therapyHepatology, 2007
- Viral Hepatitis in HIV InfectionNew England Journal of Medicine, 2007
- Single (B or C), dual (BC or BD) and triple (BCD) viral hepatitis in HIV-infected patients in Madrid, SpainAIDS, 2005
- Unsafe Sex and Increased Incidence of Hepatitis C Virus Infection among HIV-Infected Men Who Have Sex with Men: The Swiss HIV Cohort StudyClinical Infectious Diseases, 2005
- Co-infecção HIV e vírus da hepatite B: prevalência e fatores de riscoRevista da Sociedade Brasileira de Medicina Tropical, 2004
- HIV/HBV and HIV/HCV coinfection, and outcomes following highly active antiretroviral therapyHIV Medicine, 2003
- Hepatitis B and C in HIV-infected patientsJournal of Hepatology, 1997
- Serologic Diagnosis of Acute and Chronic Viral HepatitisSeminars in Liver Disease, 1991